International Society of Surgery (ISS)

Société Internationale de Chirurgie (SIC)

Integrated Societies: IATSIC | IASMEN | BSI | ISDS

CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF SUB-SAHARAN AFRICAN PATIENTS WITH BREAST PATHOLOGY TREATED IN PORTUGAL: A RETROSPECTIVE COHORT STUDY jfmarques@ulslo.min-saude.pt

 
CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF SUB-SAHARAN AFRICAN PATIENTS WITH BREAST PATHOLOGY TREATED IN PORTUGAL: A RETROSPECTIVE COHORT STUDY
Author Details
8
Including the presenting author
Joana Pedro Marques jfmarques@ulslo.min-saude.pt ULSLO General Surgery Lisboa Portugal *
Diogo Monteiro dlmonteiro@ulslo.min-saude.pt ULSLO General Surgery Lisboa Portugal
Ana Rita Martins argomartins@ulslo.min-saude.pt ULSLO General Surgery - Senology Lisboa Portugal
Zacharoula Sidiropoulou zsidiropoulou@ulslo.min-saude.pt ULSLO General Surgery - Senology Lisboa Portugal
Carlos Nascimento jfmarques@ulslo.min-saude.pt ULSLO General Surgery Lisboa Portugal
Helena Leandro hleandro@ulslo.min-saude.pt ULSLO General Surgery Lisboa Portugal
Tomás Nunes tnunes@ulslo.min-saude.pt ULSLO General Surgery Lisboa Portugal
Miguel Silvestre mjsilvestre@ulslo.min-saude.pt ULSLO General Surgery Lisboa Portugal
 
 
 
 
Joana Pedro Marques
jfmarques@ulslo.min-saude.pt
Portugal
Abstract
Poster Exhibition only
Breast pathology represents a significant healthcare burden in Sub-Saharan Africa, with limited diagnostic and treatment resources often necessitating international medical cooperation. This study aimed to characterize the demographic, clinical, and pathological features of Sub-Saharan African patients with breast pathology treated in Portugal.
We conducted a retrospective cohort study analyzing 57 female patients from Portuguese-speaking African countries (PALOP) referred to Portugal for breast pathology evaluation and treatment. Patients were categorized into benign (n=33) and malignant (n=24) pathology groups. Demographic characteristics, reproductive history, clinical presentation, diagnostic evaluation, pathological findings, and treatment approaches were analyzed.
The mean age was 37.5 years for patients with benign pathology and 42.5 years for those with malignant pathology. In the malignant group, 29.2% presented with metastatic disease (stage IV), while an equal proportion (29.2%) presented with early-stage disease (up to stage IIb). Most patients (95.8%) with malignant pathology were symptomatic upon referral, with palpable breast mass being the predominant presenting symptom. The mean time to first consultation in Portugal was 52.72 days for patients with benign pathology. Only 54.2% of malignant cases required surgery in Portugal, with the remainder having undergone surgical intervention in their country of origin.
This study highlights the diverse spectrum of breast pathology in patients referred from Sub-Saharan Africa to Portugal, ranging from benign conditions to advanced malignancy. The equal distribution of early and late-stage malignancies suggests potential opportunities for optimization of referral criteria. These findings may inform international medical cooperation strategies and resource allocation for breast pathology management.
 
Only accept images in .jpg or .png format. The image size must not exceed 1 MB.
 
Only accept images in .jpg or .png format. The image size must not exceed 1 MB.
Category
5 Breast Surgery organized by BSI
5.02 Breast Cancer
Withdrawn
0
Abstract Prizes
No
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript conforming to the format of orignial articles in the World Journal of Surgery WJS by 30 November 2025
No
- Author must be age 40 or younger
- One of the authors must be a member of ISDS
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript to the World Journal of Surgery WJS by 30 November 2025
No
- Author must be age 40 or younger
- One of the authors must be a member of ISDS
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript to the World Journal of Surgery WJS by 30 November 2025